Thymoma - PubMed (original) (raw)

Review

Thymoma

H K Müller-Hermelink et al. Curr Opin Oncol. 2000 Sep.

Abstract

Thymomas are fascinating tumors because of their multifaceted clinical presentation, including an unrivaled frequency of associated paraneoplastic autoimmune diseases and an astounding histologic heterogeneity. Thus, thymomas challenge the clinician, pathologist, and immunologist alike with complex diagnostic and therapeutic problems in almost all fields of medicine, radiology, nuclear medicine, surgery, radiooncology, and pathology. This review highlights recent progress in these fields, including the new World Health Organization's classification of thymomas, and reports on the beginning discovery of the genetic basis of thymoma oncogenesis and the cellular and molecular immunopathology of thymoma-associated paraneoplastic autoimmunity.

PubMed Disclaimer

Similar articles

• State-of-the-art classification and multimodality treatment of malignant thymoma.
  Koppitz H, Rockstroh JK, Schüller H, Standop J, Skowasch D, Müller-Hermelink HK, Schmidt-Wolf IG. Koppitz H, et al. Cancer Treat Rev. 2012 Aug;38(5):540-8. doi: 10.1016/j.ctrv.2011.11.010. Epub 2012 Jan 13. Cancer Treat Rev. 2012. PMID: 22244677 Review.
• [Lack of uniformity in the treatment of thymomas].
  Abildgaard J, Pappot H, Petersen PM, Rørth M, Pedersen JH, Santoni-Rugiu E, Daugaard G. Abildgaard J, et al. Ugeskr Laeger. 2012 Dec 10;174(50):3164-9. Ugeskr Laeger. 2012. PMID: 23286768 Danish.
• [Thymomas].
  Marx A, Weis CA, Ströbel P. Marx A, et al. Pathologe. 2016 Sep;37(5):412-24. doi: 10.1007/s00292-016-0223-3. Pathologe. 2016. PMID: 27558364 Review. German.
• [Thymic carcinomas].
  Ströbel P, Weis CA, Marx A. Ströbel P, et al. Pathologe. 2016 Sep;37(5):425-33. doi: 10.1007/s00292-016-0194-4. Pathologe. 2016. PMID: 27538748 Review. German.
• Thymoma.
  Morgenthaler TI, Brown LR, Colby TV, Harper CM Jr, Coles DT. Morgenthaler TI, et al. Mayo Clin Proc. 1993 Nov;68(11):1110-23. doi: 10.1016/s0025-6196(12)60907-0. Mayo Clin Proc. 1993. PMID: 8231276 Review.

Cited by

• Complicating autoimmune diseases in myasthenia gravis: a review.
  Nacu A, Andersen JB, Lisnic V, Owe JF, Gilhus NE. Nacu A, et al. Autoimmunity. 2015;48(6):362-8. doi: 10.3109/08916934.2015.1030614. Epub 2015 Apr 27. Autoimmunity. 2015. PMID: 25915571 Free PMC article. Review.
• Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
  Fattorossi A, Battaglia A, Buzzonetti A, Ciaraffa F, Scambia G, Evoli A. Fattorossi A, et al. Immunology. 2005 Sep;116(1):134-41. doi: 10.1111/j.1365-2567.2005.02220.x. Immunology. 2005. PMID: 16108825 Free PMC article.
• Analysis of Pulmonary Function in Thymoma Subjects: A 20-Year Retrospective Cohort Study.
  Ruan H, Liu B, Yang X, Shang X, Li Q. Ruan H, et al. Thorac Cardiovasc Surg. 2023 Aug;71(5):425-431. doi: 10.1055/s-0042-1749320. Epub 2022 Jul 27. Thorac Cardiovasc Surg. 2023. PMID: 35896441 Free PMC article.
• Epidemiology of thymoma and associated malignancies.
  Engels EA. Engels EA. J Thorac Oncol. 2010 Oct;5(10 Suppl 4):S260-5. doi: 10.1097/JTO.0b013e3181f1f62d. J Thorac Oncol. 2010. PMID: 20859116 Free PMC article. Review.
• cFLIP overexpression in T cells in thymoma-associated myasthenia gravis.
  Belharazem D, Schalke B, Gold R, Nix W, Vitacolonna M, Hohenberger P, Roessner E, Schulze TJ, Saruhan-Direskeneli G, Yilmaz V, Ott G, Ströbel P, Marx A. Belharazem D, et al. Ann Clin Transl Neurol. 2015 Sep;2(9):894-905. doi: 10.1002/acn3.210. Epub 2015 Jul 22. Ann Clin Transl Neurol. 2015. PMID: 26401511 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information